Product Details for ANDA 075155
ISOSORBIDE MONONITRATE (ISOSORBIDE MONONITRATE)
30MG
Marketing Status: Prescription
60MG
Marketing Status: Prescription
120MG
Marketing Status: Prescription
30MG
Marketing Status: Prescription
Active Ingredient: ISOSORBIDE MONONITRATE
Proprietary Name: ISOSORBIDE MONONITRATE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075155
Product Number: 002
Approval Date: Jan 13, 2000
Applicant Holder Full Name: CHARTWELL MOLECULAR HOLDINGS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
ISOSORBIDE MONONITRATE (ISOSORBIDE MONONITRATE)
Proprietary Name: ISOSORBIDE MONONITRATE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075155
Product Number: 002
Approval Date: Jan 13, 2000
Applicant Holder Full Name: CHARTWELL MOLECULAR HOLDINGS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
60MG
Marketing Status: Prescription
Active Ingredient: ISOSORBIDE MONONITRATE
Proprietary Name: ISOSORBIDE MONONITRATE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 60MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075155
Product Number: 001
Approval Date: Oct 30, 1998
Applicant Holder Full Name: CHARTWELL MOLECULAR HOLDINGS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
ISOSORBIDE MONONITRATE (ISOSORBIDE MONONITRATE)
Proprietary Name: ISOSORBIDE MONONITRATE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 60MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075155
Product Number: 001
Approval Date: Oct 30, 1998
Applicant Holder Full Name: CHARTWELL MOLECULAR HOLDINGS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
120MG
Marketing Status: Prescription
Active Ingredient: ISOSORBIDE MONONITRATE
Proprietary Name: ISOSORBIDE MONONITRATE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 120MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075155
Product Number: 003
Approval Date: Aug 4, 2000
Applicant Holder Full Name: CHARTWELL MOLECULAR HOLDINGS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: ISOSORBIDE MONONITRATE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 120MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075155
Product Number: 003
Approval Date: Aug 4, 2000
Applicant Holder Full Name: CHARTWELL MOLECULAR HOLDINGS LLC
Marketing Status: Prescription
Patent and Exclusivity Information